https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2022/QIAGEN-launches-new-solutions-that-significantly-accelerate-DNA-variant-detection-and-RNA-sequencing-of-low-input-samples/default.aspx
Canaccord Genuity Maintains Buy on Trupanion, Raises Price Target to $72
Canaccord Genuity analyst Maria Ripps maintains Trupanion (NASDAQ:TRUP) with a Buy and raises the price target from $66 to $72.